224 related articles for article (PubMed ID: 27497176)
1. Detecting Allosteric Networks Using Molecular Dynamics Simulation.
Bowerman S; Wereszczynski J
Methods Enzymol; 2016; 578():429-47. PubMed ID: 27497176
[TBL] [Abstract][Full Text] [Related]
2. The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin.
Vijayalakshmi J; Padmanabhan KP; Mann KG; Tulinsky A
Protein Sci; 1994 Dec; 3(12):2254-71. PubMed ID: 7756983
[TBL] [Abstract][Full Text] [Related]
3. The effects of exosite occupancy on the substrate specificity of thrombin.
Ng NM; Quinsey NS; Matthews AY; Kaiserman D; Wijeyewickrema LC; Bird PI; Thompson PE; Pike RN
Arch Biochem Biophys; 2009 Sep; 489(1-2):48-54. PubMed ID: 19638274
[TBL] [Abstract][Full Text] [Related]
4. Multiple inhibitory kinetics reveal an allosteric interplay among thrombin functional sites.
Zavyalova E; Kopylov A
Thromb Res; 2015 Jan; 135(1):212-6. PubMed ID: 25467079
[TBL] [Abstract][Full Text] [Related]
5. The role of Glu(192) in the allosteric control of the S(2)' and S(3)' subsites of thrombin.
Marque PE; Spuntarelli R; Juliano L; Aiach M; Le Bonniec BF
J Biol Chem; 2000 Jan; 275(2):809-16. PubMed ID: 10625611
[TBL] [Abstract][Full Text] [Related]
6. Allosteric changes of thrombin catalytic site induced by interaction of bothrojaracin with anion-binding exosites I and II.
Monteiro RQ; Rapôso JG; Wisner A; Guimarães JA; Bon C; Zingali RB
Biochem Biophys Res Commun; 1999 Sep; 262(3):819-22. PubMed ID: 10471408
[TBL] [Abstract][Full Text] [Related]
7. NMR reveals a dynamic allosteric pathway in thrombin.
Handley LD; Fuglestad B; Stearns K; Tonelli M; Fenwick RB; Markwick PR; Komives EA
Sci Rep; 2017 Jan; 7():39575. PubMed ID: 28059082
[TBL] [Abstract][Full Text] [Related]
8. Revisiting antithrombotic therapeutics; sculptin, a novel specific, competitive, reversible, scissile and tight binding inhibitor of thrombin.
Iqbal A; Goldfeder MB; Marques-Porto R; Asif H; Souza JG; Faria F; Chudzinski-Tavassi AM
Sci Rep; 2017 May; 7(1):1431. PubMed ID: 28469161
[TBL] [Abstract][Full Text] [Related]
9. Structural and Functional Characterization of Hirudin P6 Derived Novel Bivalent Thrombin Inhibitors - Studying the Effect of Linker Length and Glycosylation on Their Function.
Shabareesh P; Kaur KJ
Chem Biol Drug Des; 2016 Jul; 88(1):129-41. PubMed ID: 26850929
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of fluid phase and clot-bound thrombin by the thrombin exosite I ligand LU 58463: comparison with heparin and hirudin.
Filippucci E; Agnelli G; Leone M; Nenci GG
Haematologica; 2002 Oct; 87(10):1116-7. PubMed ID: 12368171
[No Abstract] [Full Text] [Related]
11. Na
Xiao J; Salsbury FR
Phys Chem Chem Phys; 2019 Feb; 21(8):4320-4330. PubMed ID: 30724273
[TBL] [Abstract][Full Text] [Related]
12. Rapid Characterization of Allosteric Networks with Ensemble Normal Mode Analysis.
Yao XQ; Skjærven L; Grant BJ
J Phys Chem B; 2016 Aug; 120(33):8276-88. PubMed ID: 27056373
[TBL] [Abstract][Full Text] [Related]
13. Dynamic allostery-based molecular workings of kinase:peptide complexes.
Ahuja LG; Aoto PC; Kornev AP; Veglia G; Taylor SS
Proc Natl Acad Sci U S A; 2019 Jul; 116(30):15052-15061. PubMed ID: 31285328
[TBL] [Abstract][Full Text] [Related]
14. Structure of the hirugen and hirulog 1 complexes of alpha-thrombin.
Skrzypczak-Jankun E; Carperos VE; Ravichandran KG; Tulinsky A; Westbrook M; Maraganore JM
J Mol Biol; 1991 Oct; 221(4):1379-93. PubMed ID: 1942057
[TBL] [Abstract][Full Text] [Related]
15. Dynamic properties of the native free antithrombin from molecular dynamics simulations: computational evidence for solvent- exposed Arg393 side chain.
Tóth L; Fekete A; Balogh G; Bereczky Z; Komáromi I
J Biomol Struct Dyn; 2015 Sep; 33(9):2023-36. PubMed ID: 25483839
[TBL] [Abstract][Full Text] [Related]
16. Causality, transfer entropy, and allosteric communication landscapes in proteins with harmonic interactions.
Hacisuleyman A; Erman B
Proteins; 2017 Jun; 85(6):1056-1064. PubMed ID: 28241380
[TBL] [Abstract][Full Text] [Related]
17. Neutron and X-ray crystallographic analysis of the human α-thrombin-bivalirudin complex at pD 5.0: protonation states and hydration structure of the enzyme-product complex.
Yamada T; Kurihara K; Ohnishi Y; Tamada T; Tomoyori K; Masumi K; Tanaka I; Kuroki R; Niimura N
Biochim Biophys Acta; 2013 Aug; 1834(8):1532-8. PubMed ID: 23712263
[TBL] [Abstract][Full Text] [Related]
18. Correlated motions and residual frustration in thrombin.
Fuglestad B; Gasper PM; McCammon JA; Markwick PR; Komives EA
J Phys Chem B; 2013 Oct; 117(42):12857-63. PubMed ID: 23621631
[TBL] [Abstract][Full Text] [Related]
19. Thrombin allosteric modulation revisited: a molecular dynamics study.
de Amorim HL; Netz PA; Guimarães JA
J Mol Model; 2010 Apr; 16(4):725-35. PubMed ID: 19816721
[TBL] [Abstract][Full Text] [Related]
20. Drug repurposing for chronic myeloid leukemia: in silico and in vitro investigation of DrugBank database for allosteric Bcr-Abl inhibitors.
Singh VK; Chang HH; Kuo CC; Shiao HY; Hsieh HP; Coumar MS
J Biomol Struct Dyn; 2017 Jun; 35(8):1833-1848. PubMed ID: 27353341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
